Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care.
Kirchhof P, Pecen L, Bakhai A, de Asmundis C, de Groot JR, Deharo JC, Kelly P, Levy P, Lopez-de-Sa E, Monteiro P, Steffel J, Waltenberger J, Weiss TW, Laeis P, Manu MC, Souza J, De Caterina R. Kirchhof P, et al. Among authors: de asmundis c, de groot jr, de caterina r. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):47-57. doi: 10.1093/ehjcvp/pvac042. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35881467 Free PMC article.
A score model to predict risk of events in patients with Brugada Syndrome.
Sieira J, Conte G, Ciconte G, Chierchia GB, Casado-Arroyo R, Baltogiannis G, Di Giovanni G, Saitoh Y, Juliá J, Mugnai G, La Meir M, Wellens F, Czapla J, Pappaert G, de Asmundis C, Brugada P. Sieira J, et al. Among authors: de asmundis c. Eur Heart J. 2017 Jun 7;38(22):1756-1763. doi: 10.1093/eurheartj/ehx119. Eur Heart J. 2017. PMID: 28379344
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study.
De Caterina R, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Weiss TW, Waltenberger J, Steffel J, de Groot JR, Levy P, Bakhai A, Zierhut W, Laeis P, Reimitz PE, Kirchhof P; ETNA-AF-Europe investigators. De Caterina R, et al. Among authors: de asmundis c, de groot jr. J Cardiovasc Med (Hagerstown). 2019 Feb;20(2):97-104. doi: 10.2459/JCM.0000000000000737. J Cardiovasc Med (Hagerstown). 2019. PMID: 30540648 Free article.
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).
De Caterina R, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Weiss TW, Waltenberger J, Steffel J, de Groot JR, Levy P, Bakhai A, Zierhut W, Laeis P, Kerschnitzki M, Reimitz PE, Kirchhof P; ETNA-AF-Europe investigators. De Caterina R, et al. Among authors: de asmundis c, de groot jr. BMC Cardiovasc Disord. 2019 Jul 12;19(1):165. doi: 10.1186/s12872-019-1144-x. BMC Cardiovasc Disord. 2019. PMID: 31299906 Free PMC article.
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study.
de Groot JR, Weiss TW, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Waltenberger J, Steffel J, Levy P, Bakhai A, Zierhut W, Laeis P, Manu MC, Reimitz PE, De Caterina R, Kirchhof P. de Groot JR, et al. Among authors: de asmundis c, de caterina r. Eur Heart J Cardiovasc Pharmacother. 2021 Apr 9;7(FI1):f30-f39. doi: 10.1093/ehjcvp/pvaa079. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 32790837 Free PMC article.
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study.
de Vries TAC, Hemels MEW, Cools F, Crijns HJGM, Yperzeele L, Vanacker P, Blankoff I, Lancellotti P, Mairesse GH, de Veer A, Casado Arroyo R, Catez E, de Pauw M, Vanassche T, de Asmundis C, Kirchhof P, De Caterina R, de Groot JR; ETNA-AF-Europe principal investigators from Belgium and the Netherlands. de Vries TAC, et al. Among authors: de asmundis c, de groot jr, de veer a, de pauw m, de caterina r. Acta Cardiol. 2021 Jun;76(4):431-439. doi: 10.1080/00015385.2020.1746095. Epub 2021 Jan 7. Acta Cardiol. 2021. PMID: 33406996 Free article.
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study.
de Vries TAC, Hemels MEW, Cools F, Crijns HJGM, Yperzeele L, Vanacker P, Blankoff I, Lancellotti P, Mairesse GH, de Veer A, Casado Arroyo R, Catez E, de Pauw M, Vanassche T, de Asmundis C, Kirchhof P, De Caterina R, de Groot JR; ETNA-AF-Europe principal investigators from Belgium and the Netherlands*. de Vries TAC, et al. Among authors: de asmundis c, de groot jr, de veer a, de pauw m, de caterina r. Neth Heart J. 2021 Mar;29(3):158-167. doi: 10.1007/s12471-020-01518-7. Epub 2021 Jan 7. Neth Heart J. 2021. PMID: 33411231 Free PMC article.
A failed catheter ablation of atrial fibrillation is associated with more advanced remodeling and reduced efficacy of further thoracoscopic ablation.
Wesselink R, Vroomen M, Overeinder I, Neefs J, van den Berg NWE, Meulendijks ER, Piersma FR, Al-Shama RFM, de Vries TAC, Verstraelen TE, Luermans J, Maesen B, de Asmundis C, Chierchia GB, La Meir M, Pison L, van Boven WJP, Driessen AHG, de Groot JR. Wesselink R, et al. Among authors: de asmundis c, de groot jr, de vries tac. Rev Esp Cardiol (Engl Ed). 2023 Jun;76(6):417-426. doi: 10.1016/j.rec.2022.09.006. Epub 2022 Sep 22. Rev Esp Cardiol (Engl Ed). 2023. PMID: 36155846 Free article. English, Spanish.
Left atrial function after standalone totally thoracoscopic left atrial appendage exclusion in atrial fibrillation patients with absolute contraindication to oral anticoagulation therapy.
Marini M, Pannone L, Branzoli S, Tedoldi F, D'Onghia G, Fanti D, Sarao E, Guarracini F, Quintarelli S, Monaco C, Graffigna A, Bonmassari R, La Meir M, Chierchia GB, de Asmundis C. Marini M, et al. Among authors: de asmundis c. Front Cardiovasc Med. 2022 Nov 7;9:1036574. doi: 10.3389/fcvm.2022.1036574. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36419499 Free PMC article.
Radiation dose reduction in the setting of cryoballoon ablation for atrial fibrillation: the value of optimized fluoroscopy settings and intracardiac echocardiography.
Velagic V, Mugnai G, Prepolec I, Pasara V, Puljevic M, Pezo-Nikolic B, Puljević D, de Asmundis C, Chierchia GB, Milicic D. Velagic V, et al. Among authors: de asmundis c. Int J Cardiovasc Imaging. 2023 Jan;39(1):245-254. doi: 10.1007/s10554-022-02717-6. Epub 2022 Aug 28. Int J Cardiovasc Imaging. 2023. PMID: 36598699
449 results